# Primary Tumor Burden Score:A Novel Staging Parameter for ESCC After nCRT

> **NCT05839002** · — · COMPLETED · sponsor: **Fudan University** · enrollment: 187 (actual)

## Conditions studied

- Neoplasm, Esophagus
- Neoplasm, Squamous Cell

## Interventions

- **PROCEDURE:** nCRT

## Key facts

- **NCT ID:** NCT05839002
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-21
- **Primary completion:** 2021-12-01
- **Final completion:** 2023-03-15
- **Target enrollment:** 187 (ACTUAL)
- **Last updated:** 2023-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05839002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05839002, "Primary Tumor Burden Score:A Novel Staging Parameter for ESCC After nCRT". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05839002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*